Enhancing sensitivity to PARP inhibitors

被引：0
|
作者：
Sarah Crunkhorn
机构：
来源：
Nature Reviews Drug Discovery | 2021年 / 20卷 / 6期
关键词：
D O I：
10.1038/d41573-021-00078-8
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：426 / 426
相关论文
共 50 条
  • [31] PARP inhibitors plough on
    Mullard, Asher
    NATURE REVIEWS DRUG DISCOVERY, 2017, 16 (04) : 229 - 229
  • [32] Profiling PARP inhibitors
    Jones, Philip
    NATURE BIOTECHNOLOGY, 2012, 30 (03) : 249 - 250
  • [33] Profiling PARP inhibitors
    Philip Jones
    Nature Biotechnology, 2012, 30 : 249 - 250
  • [34] EGFR amplification predicted selective sensitivity to PARP inhibitors with high PARP-DNA trapping potential in human GBM.
    Yung, W. K. Alfred
    Wu, Shaofang
    Gao, Feng
    Zheng, Siyuan
    Ding, Jie
    Zhang, Chen
    Li, Xialong
    Ezhilarasan, Ravesanker
    Feng, Ningping
    De Groot, John Frederick
    Sulman, Erik P.
    Heffernan, Timothy
    Koul, Dimpy
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [35] MUTATIONS IN ATRX INCREASE GENETIC INSTABILITY AND SENSITIVITY TO PARP INHIBITORS IN PAEDIATRIC GLIOBLASTOMA CELLS
    Fazal-Salom, Janat
    Vinci, Mara
    Carvalho, Diana
    Pemberton, Helen
    Pettit, Steve
    Lord, Christopher
    Mackay, Alan
    Bjerke, Lynn
    Jones, Chris
    NEURO-ONCOLOGY, 2017, 19 : 24 - 24
  • [36] ATM Deficiency Is Associated with Sensitivity to PARP1-and ATR Inhibitors in Lung Adenocarcinoma
    Schmitt, Anna
    Knittel, Gero
    Welcker, Daniela
    Yang, Tsun-Po
    George, Julie
    Nowak, Michael
    Leeser, Uschi
    Buettner, Reinhard
    Perner, Sven
    Peifer, Martin
    Reinhardt, Hans Christian
    CANCER RESEARCH, 2017, 77 (11) : 3040 - 3056
  • [37] An assay for evaluation of homologous recombination activity in tumor tissues to predict sensitivity to PARP inhibitors
    Yoshino, Yuki
    Motonari, Tokiwa
    Endo, Shino
    Miyashita, Minoru
    Tada, Hiroshi
    Watanabe, Go
    Ishida, Takanori
    Chiba, Natsuko
    CANCER SCIENCE, 2025, 116 : 1853 - 1853
  • [38] RAD50 Deficient in a Breast Cancer Model Predicts Sensitivity to PARP Inhibitors
    Ramos, Cintia Regina Niederauer
    Oliveira, Renato Jose Silva
    Rosa, Marcela Nunes
    Pereira, Ariane Stefani
    de Abreu, Renata Barbosa Vahia
    Lengert, Andre van Helvoort
    Reis, Rui Manuel
    Silva, Viviane Aline Oliveira
    Palmero, Edenir Inez
    Melendez, Matias Eliseo
    CURRENT CANCER DRUG TARGETS, 2023, 23 (11) : 900 - 909
  • [39] Mutations in ATRX increase genetic instability and sensitivity to PARP inhibitors in paediatric glioblastoma cells
    Fazal-Salom, Janat
    Vinci, Mara
    Carvalho, Diana
    Pemberton, Helen
    Pettitt, Stephen J.
    Lord, Christopher J.
    Mackay, Alan
    Bjerke, Lynn
    Jones, Chris
    CANCER RESEARCH, 2017, 77
  • [40] Schlafen 11 (SLFN11) is a critical determinant of cellular sensitivity to PARP inhibitors
    Murai, Junko
    Josse, Rozenn
    Doroshow, James H.
    Pommier, Yves
    CANCER RESEARCH, 2014, 74 (19)
12345